Arbitration Issues in Medical Device Cross-Licensing Arrangements

Introduction

Medical device cross-licensing arrangements are agreements whereby two or more medical device companies mutually grant rights to use each other's patents, know-how, software, manufacturing technologies, trade secrets, or regulatory data relating to medical devices. Cross-licensing is particularly prevalent in industries involving implantable devices, diagnostic equipment, robotic surgery systems, prosthetics, imaging devices, and digital health technologies. Such arrangements allow parties to avoid infringement litigation, facilitate innovation, reduce transaction costs, and accelerate commercialization. Cross-licensing frequently arises because modern medical devices incorporate numerous patented technologies owned by different entities.

Because medical devices involve highly valuable intellectual property, regulatory obligations, and cross-border commercialization, disputes under cross-licensing agreements frequently culminate in arbitration. Arbitration is generally preferred due to confidentiality, technical expertise, procedural flexibility, and enforceability of awards in multiple jurisdictions.

Nature of Medical Device Cross-Licensing Agreements

A typical medical device cross-licensing arrangement covers:

1. Patent licenses
2. Technology transfer rights
3. Software and algorithm usage rights
4. Manufacturing know-how
5. Regulatory data sharing
6. Confidential information and trade secrets
7. Improvements and future inventions
8. Royalty obligations
9. Territorial commercialization rights
10. Dispute resolution mechanisms

Examples include collaborations involving pacemakers, artificial implants, pulmonary devices, surgical robotics, and digital diagnostic technologies.

Major Arbitration Issues in Medical Device Cross-Licensing Arrangements

1. Determination of Scope of Licensed Patents

One of the most common disputes concerns whether a particular medical device falls within the scope of licensed patents.

Questions generally include:

• Whether new device versions are covered
• Whether modifications constitute derivative inventions
• Whether software updates amount to new inventions
• Whether additional components fall within licensed claims

Medical devices evolve rapidly, and parties frequently disagree on whether subsequent technologies are included within the original cross-license.

Arbitrators often require:

• Patent claim construction
• Technical expert testimony
• Engineering evidence
• Product comparison analyses

Such disputes become especially complex in products integrating hardware and software technologies.

2. Ownership of Improvements and Future Technologies

Cross-licensing agreements usually contain clauses concerning:

• Joint developments
• Improvements
• Derivative inventions
• Future patents

Disputes arise when:

• One party independently develops improved versions;
• Improvements incorporate technologies of both parties;
• New inventions substantially modify original technology.

Questions before tribunals include:

• Who owns the improvement?
• Whether improvements automatically become cross-licensed?
• Whether separate royalties are payable?
• Whether one party may seek independent patent protection?

Determining ownership of future inventions often requires detailed examination of R&D records and inventorship evidence.

3. Royalty Calculation Disputes

Royalty disputes are among the most frequent issues in medical device licensing arbitrations.

Disagreements may involve:

• Net sales calculations
• Transfer pricing
• Bundled products
• Multi-component devices
• Royalty stacking
• Currency conversion
• Minimum guarantee payments

For example, a surgical robotic system may contain numerous licensed technologies. Parties often disagree regarding the proportion of revenues attributable to specific licensed patents.

Arbitrators frequently appoint:

• Financial experts
• Forensic accountants
• Valuation specialists
• Industry experts

to determine proper royalty calculations.

4. Patent Validity and Arbitrability Issues

Medical device licenses revolve around patent rights.

Disputes may involve:

• Patent validity
• Patent enforceability
• Patent infringement allegations
• Scope of claims

The arbitrability of patent issues varies among jurisdictions.

Generally:

• Contractual rights under patents are arbitrable.
• Inter partes validity disputes are often arbitrable.
• Erga omnes revocation of patents usually remains within statutory authorities.

This distinction becomes significant in cross-border medical device licensing arrangements where patents exist in multiple jurisdictions.

5. Confidentiality and Trade Secret Protection

Medical devices involve extremely sensitive information, including:

• Source code
• Manufacturing methods
• Device specifications
• Clinical data
• Design schematics
• Regulatory submissions

Litigation may expose confidential information to competitors.

Arbitration is therefore preferred because it permits:

• Closed hearings
• Confidential filings
• Protective orders
• Limited disclosure

Nevertheless, disputes arise regarding:

• Unauthorized disclosures;
• Use of confidential information beyond license scope;
• Reverse engineering;
• Misappropriation of manufacturing know-how.

Tribunals frequently issue confidentiality directions and protective procedural orders.

6. Regulatory Compliance Disputes

Medical devices are heavily regulated.

Cross-licensed technologies often require compliance with:

• Safety standards
• Quality certifications
• Clinical testing requirements
• Manufacturing standards
• Post-market surveillance obligations

Disputes arise when:

• One party fails to obtain approvals;
• Regulatory submissions contain inaccurate data;
• Product recalls occur;
• Non-compliance causes commercialization delays.

Arbitrators often examine:

• Regulatory obligations;
• Allocation of responsibilities;
• Indemnity provisions;
• Causation and damages.

7. Product Liability and Indemnification

Medical devices can directly affect human health.

Disputes frequently concern:

• Defective products;
• Manufacturing defects;
• Design failures;
• Software malfunction;
• Patient injuries.

Cross-license agreements usually contain indemnity clauses.

Arbitration often focuses on:

• Allocation of liability;
• Contributory fault;
• Manufacturing responsibility;
• Insurance coverage;
• Scope of indemnification.

Determining causation often requires complex scientific evidence.

8. Territorial Restrictions and Commercialization Rights

Cross-licensing agreements commonly divide markets geographically.

Disputes arise regarding:

• Unauthorized sales;
• Parallel imports;
• Territorial infringement;
• Competing commercialization activities.

Questions include:

• Whether one party exceeded territorial rights;
• Whether online sales violate exclusivity;
• Whether distributors can operate in restricted territories.

International arbitration becomes necessary because commercialization frequently spans numerous countries.

9. Competition Law Concerns

Cross-licensing agreements may potentially raise competition concerns, such as:

• Market allocation;
• Price restrictions;
• Exclusive dealing;
• Patent pools;
• Technology foreclosure.

Arbitrators may need to determine:

• Whether licensing restrictions are reasonable;
• Whether clauses violate competition regulations;
• Whether anti-competitive provisions are severable.

Competition issues become particularly significant where essential medical technologies are involved.

10. Multi-Jurisdictional Enforcement Problems

Medical device patents are territorial.

A single cross-licensing arrangement may involve:

• United States patents;
• European patents;
• Indian patents;
• Japanese patents;
• Chinese patents.

Consequently, arbitration may involve:

• Multiple governing laws;
• Different patent regimes;
• Parallel court proceedings;
• Recognition and enforcement issues.

International arbitration provides procedural efficiency and facilitates enforcement under the New York Convention framework.

Advantages of Arbitration in Medical Device Cross-Licensing Disputes

Technical Expertise

Arbitrators with backgrounds in biotechnology, engineering, and intellectual property may be appointed.

Confidentiality

Sensitive technical information remains protected.

Procedural Flexibility

Parties can tailor procedures to accommodate scientific evidence.

International Enforceability

Awards are enforceable in numerous jurisdictions.

Speed and Efficiency

Arbitration generally avoids lengthy multi-jurisdictional litigation.

Party Autonomy

Parties can choose:

• Applicable law
• Seat of arbitration
• Language
• Number of arbitrators
• Confidentiality measures

Important Case Laws

1. SBP & Co. v. Patel Engineering Ltd. (2005) 8 SCC 618

Principle: Judicial intervention in arbitration should be limited and arbitral tribunals have competence to determine issues within their jurisdiction.

Relevance: Supports referral of complex technology licensing disputes to arbitration.

2. Vidya Drolia v. Durga Trading Corporation (2021) 2 SCC 1

Principle: Commercial disputes are generally arbitrable unless expressly excluded by law.

Relevance: Medical device cross-licensing disputes concerning contractual rights and royalties ordinarily remain arbitrable.

3. In Re Medical Engineering Corporation, 976 F.2d 746 (Fed. Cir. 1992)

Principle: Patent licensing disputes concerning whether products fall within licensed patent claims may be resolved through arbitration.

Relevance: Directly addresses medical device patent licensing disputes involving penile prosthesis technology.

4. Ballard Medical Products v. Wright, 823 F.2d 527 (Fed. Cir. 1987)

Principle: Disputes regarding whether improved medical devices fall within exclusive licensing arrangements are properly referable to arbitration.

Relevance: Highly relevant for improvement ownership disputes in medical device cross-licensing arrangements.

5. Eastman Medical Products v. E.R. Squibb & Sons, 199 F.Supp.2d 590 (N.D. Tex. 2002)

Principle: Courts should respect arbitration clauses contained in technology licensing agreements and permit arbitral determination of contractual disputes.

Relevance: Demonstrates judicial support for arbitration of medical technology licensing disagreements.

6. Biotronik Mess-und Therapiegeraete GmbH & Co. v. Medford Medical Instrument Co., 415 F.Supp. 133 (D.N.J. 1976)

Principle: International arbitration awards arising from medical device distribution and licensing agreements are enforceable.

Relevance: Illustrates enforceability of arbitral awards in cross-border medical device disputes.

7. Booz Allen & Hamilton Inc. v. SBI Home Finance Ltd. (2011) 5 SCC 532

Principle: Rights in personam are generally arbitrable.

Relevance: Contractual claims under medical device cross-licenses, including royalties and indemnities, are ordinarily rights in personam and therefore arbitrable.

8. Disortho SAS v. Meril Life Sciences Private Limited (2025)

Principle: Courts must carefully reconcile competing jurisdiction and arbitration clauses in international medical product agreements.

Relevance: Demonstrates complexities arising in cross-border medical technology arrangements involving different governing laws and arbitral seats.

Conclusion

Arbitration has become the preferred mechanism for resolving disputes arising from medical device cross-licensing arrangements because such agreements involve highly technical intellectual property, confidential information, regulatory obligations, and multi-jurisdictional commercialization rights. The principal arbitration issues include patent scope determination, ownership of improvements, royalty calculations, confidentiality breaches, regulatory compliance, product liability, competition law concerns, and international enforcement challenges. Courts across jurisdictions increasingly recognize that contractual and commercial disputes arising from medical device cross-licensing arrangements are particularly suited to arbitration due to the need for expertise, confidentiality, and effective cross-border dispute resolution.